Australia markets closed

NeuroScientific Biopharmaceuticals Limited (NSB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.08000.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 11.57M
Enterprise value 6.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.46
Enterprise value/revenue N/A
Enterprise value/EBITDA -6.62

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-11.11%
S&P500 52-week change 318.47%
52-week high 30.1700
52-week low 30.0670
50-day moving average 30.0944
200-day moving average 30.0946

Share statistics

Avg vol (3-month) 380.14k
Avg vol (10-day) 347.74k
Shares outstanding 5144.6M
Implied shares outstanding 6144.6M
Float 899.68M
% held by insiders 134.23%
% held by institutions 14.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -21.58%
Operating margin (ttm)-23.65%

Management effectiveness

Return on assets (ttm)-11.24%
Return on equity (ttm)-20.92%

Income statement

Revenue (ttm)4.95M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)5,600.40%
Gross profit (ttm)4.91M
EBITDA -1.11M
Net income avi to common (ttm)-1.07M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.91M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)8.39
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-2.3M
Levered free cash flow (ttm)-1.97M